JACK NATHAN MEDICAL CORP (JNH.CA) Stock Analyst Earnings Estimates
TSX-V:JNH - TSX Venture Exchange - CA4663771083 - Common Stock - Currency: CAD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 9.639M 150.21% | 15.488M 60.68% | 19.145M 23.61% | |
| EBITDA YoY % growth | -6.396M -476.07% | -4.231M 33.85% | -4.142M 2.09% | |
| EBIT YoY % growth | -6.912M -450.71% | -5.301M 23.31% | -5.321M -0.38% | |
| Operating Margin | -71.71% | -34.23% | -27.79% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in CAD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CAD
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 5.249M 6.27% | % | ||
| Q2 2025 Q2Q % growth | 10.671M 133.58% | % | ||
| Q1 2025 Q2Q % growth | 5.279M 24.88% | % | ||
| Q4 2024 Q2Q % growth | 5.41M 46.78% | % | ||
| Q3 2024 Q2Q % growth | 4.94M 15.46% | % | ||
| Q2 2024 Q2Q % growth | 4.568M 25.82% | % | ||
| Q1 2024 Q2Q % growth | 4.227M 8.58% | % | ||
| Q4 2023 Q2Q % growth | 3.686M -8.27% | % | ||
| Q3 2023 Q2Q % growth | 4.278M 77.16% | % | ||
| Q2 2023 Q2Q % growth | 3.631M 87.20% | % | ||
| Q1 2023 Q2Q % growth | 3.893M 207.34% | % | ||
| Q4 2022 Q2Q % growth | 4.018M 458.03% | % | ||
| Q3 2022 Q2Q % growth | 2.415M 143.01% | % | ||
| Q2 2022 Q2Q % growth | 1.939M 70.05% | % | ||
| Q1 2022 Q2Q % growth | 1.267M 26.47% | % | ||
| Q4 2021 Q2Q % growth | 720K -13.59% | % | ||
| Q3 2021 Q2Q % growth | 993.69K 3.60% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |